Correspondence

Advice on the anticonvulsant drugs Pregabalin and Gabapentin

The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.

Document

ACMD advice on Pregabalin and Gabapentin

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Les Iversen, chair of the ACMD, writes to Karen Bradley, Minister for Preventing Abuse and Exploitation, recommending that Pregabalin and Gabapentin be made class C controlled substances.

Published 14 January 2016